|
Insider Trading: KERYX BIOPHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of KERYX BIOPHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of KERYX BIOPHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of KERYX BIOPHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is KERX.
The reporting company's CIK number is 1114220.
The total value of stock buying since 2005 is $124,099.
The total value of stock sales is $8,766,110.
The total value of stock exercises is $787,701.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at KERYX BIOPHARMACEUTICALS INC (KERX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at KERYX BIOPHARMACEUTICALS INC (KERX) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for KERYX BIOPHARMACEUTICALS INC (KERX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2007-11 | 1,100 | 9,581 | 0 | 0 | 0 | 0 |
| 2007-09 | 3,000 | 30,180 | 0 | 0 | 0 | 0 |
| 2007-06 | 4,900 | 52,598 | 0 | 0 | 0 | 0 |
| 2006-12 | 0 | 0 | 174,051 | 2,514,073 | 167,656 | 221,051 |
| 2006-07 | 0 | 0 | 10,000 | 115,914 | 10,000 | 13,000 |
| 2006-06 | 0 | 0 | 40,000 | 503,642 | 40,000 | 52,000 |
| 2006-05 | 0 | 0 | 40,000 | 614,788 | 40,000 | 52,000 |
| 2006-04 | 0 | 0 | 40,000 | 683,278 | 40,000 | 52,000 |
| 2006-03 | 0 | 0 | 195,000 | 3,505,882 | 195,000 | 345,650 |
| 2006-02 | 0 | 0 | 40,000 | 662,033 | 40,000 | 52,000 |
| 2005-11 | 0 | 0 | 11,100 | 166,500 | 0 | 0 |
| 2004-11 | 300 | 3,750 | 0 | 0 | 0 | 0 |
| 2003-06 | 5,000 | 8,750 | 0 | 0 | 0 | 0 |
| 2001-02 | 2,000 | 19,240 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for KERYX BIOPHARMACEUTICALS INC (KERX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-11-19 | Tarnok Michael P. (Director) | Purchase | 1,100 | 8.71 | 9,581 |
| 2007-09-28 | Fowler Wyche Jr (Director) | Purchase | 3,000 | 10.06 | 30,180 |
| 2007-06-19 | Kaye Jack (Director) | Purchase | 1,400 | 10.50 | 14,698 |
| 2007-06-18 | Levine Beth F (General Counsel and CCO) | Purchase | 1,000 | 11.00 | 11,000 |
| 2007-06-07 | Stier Mark (Chief Accounting Officer) | Purchase | 2,500 | 10.76 | 26,900 |
| 2006-12-29 | Hoenlein Malcolm (Director) | Sale | 7,000 | 13.21 | 92,470 |
| 2006-12-29 | Hoenlein Malcolm (Director) | Option Exercise | 5,000 | 1.92 | 9,600 |
| 2006-12-14 | Weiss Michael S (Chairman and CEO) | Sale | 22,887 | 14.20 | 325,109 |
| 2006-12-14 | Weiss Michael S (Chairman and CEO) | Option Exercise | 22,887 | 1.30 | 29,753 |
| 2006-12-13 | Weiss Michael S (Chairman and CEO) | Sale | 21,337 | 14.36 | 306,434 |
| 2006-12-13 | Weiss Michael S (Chairman and CEO) | Option Exercise | 21,337 | 1.30 | 27,738 |
| 2006-12-12 | Weiss Michael S (Chairman and CEO) | Sale | 15,000 | 14.43 | 216,510 |
| 2006-12-12 | Weiss Michael S (Chairman and CEO) | Option Exercise | 15,000 | 1.30 | 19,500 |
| 2006-12-11 | Weiss Michael S (Chairman and CEO) | Sale | 22,895 | 14.52 | 331,481 |
| 2006-12-11 | Weiss Michael S (Chairman and CEO) | Option Exercise | 22,895 | 1.30 | 29,763 |
| 2006-12-08 | Weiss Michael S (Chairman and CEO) | Sale | 27,102 | 14.61 | 396,034 |
| 2006-12-08 | Weiss Michael S (Chairman and CEO) | Option Exercise | 27,102 | 1.30 | 35,232 |
| 2006-12-07 | Weiss Michael S (Chairman and CEO) | Sale | 53,435 | 14.63 | 781,948 |
| 2006-12-07 | Weiss Michael S (Chairman and CEO) | Option Exercise | 53,435 | 1.30 | 69,465 |
| 2006-07-18 | Weiss Michael S (Chairman and CEO) | Sale | 10,000 | 11.59 | 115,914 |
| 2006-07-18 | Weiss Michael S (Chairman and CEO) | Option Exercise | 10,000 | 1.30 | 13,000 |
| 2006-06-20 | Weiss Michael S (Chairman and CEO) | Sale | 40,000 | 12.59 | 503,642 |
| 2006-06-20 | Weiss Michael S (Chairman and CEO) | Option Exercise | 40,000 | 1.30 | 52,000 |
| 2006-05-17 | Weiss Michael S (Chairman and CEO) | Sale | 15,000 | 14.98 | 224,650 |
| 2006-05-16 | Weiss Michael S (Chairman and CEO) | Sale | 25,000 | 15.61 | 390,138 |
| 2006-05-16 | Weiss Michael S (Chairman and CEO) | Option Exercise | 40,000 | 1.30 | 52,000 |
| 2006-04-18 | Weiss Michael S (Chariman and CEO) | Sale | 40,000 | 17.08 | 683,278 |
| 2006-04-18 | Weiss Michael S (Chariman and CEO) | Option Exercise | 40,000 | 1.30 | 52,000 |
| 2006-03-29 | Bentsur Ron (Chief Accounting Officer) | Sale | 35,000 | 18.84 | 659,276 |
| 2006-03-29 | Bentsur Ron (Chief Accounting Officer) | Option Exercise | 35,000 | 1.10 | 38,500 |
| 2006-03-21 | Weiss Michael S (Chairman and CEO) | Sale | 80,000 | 18.33 | 1,466,045 |
| 2006-03-21 | Weiss Michael S (Chairman and CEO) | Option Exercise | 80,000 | 1.30 | 104,000 |
| 2006-03-14 | Rose Eric A Md (Director) | Sale | 5,000 | 18.11 | 90,561 |
| 2006-03-14 | Rose Eric A Md (Director) | Option Exercise | 5,000 | 11.83 | 59,150 |
| 2006-03-08 | Kessel Larry (Director) | Sale | 75,000 | 17.20 | 1,290,000 |
| 2006-03-08 | Kessel Larry (Director) | Option Exercise | 75,000 | 1.92 | 144,000 |
| 2006-02-21 | Weiss Michael S (Chairman and CEO) | Sale | 40,000 | 16.55 | 662,033 |
| 2006-02-21 | Weiss Michael S (Chairman and CEO) | Option Exercise | 40,000 | 1.30 | 52,000 |
| 2005-11-21 | Salomon Peter (Director) | Sale | 11,100 | 15.00 | 166,500 |
| 2004-11-18 | Salomon Peter (Director) | Purchase | 300 | 12.50 | 3,750 |
| 2003-06-04 | Weiss Michael S (Chief Executive Officer) | Purchase | 5,000 | 1.75 | 8,750 |
| 2001-02-02 | Hoenlein Malcolm (Director) | Purchase | 2,000 | 9.62 | 19,240 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of KERYX BIOPHARMACEUTICALS INC (symbol KERX,
CIK number 1114220) see
the Securities and Exchange Commission (SEC) website.
|
|
